Ratings by Barclays
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/1/2026 | Saket Kalia | SailPoint Technologies Holdings | SAIL | Maintain | Overweight (N/A) |
21.00 (19.00) |
|
Details | |
| 9/1/2026 | Etzer Darout | Protagonist Therapeutics | PTGX | Maintain | Overweight (N/A) |
180.00 (153.00) |
|
Details | |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 37,009 more... | |||||||||


